512 related articles for article (PubMed ID: 27206524)
1. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L
Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128
[TBL] [Abstract][Full Text] [Related]
4. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
[TBL] [Abstract][Full Text] [Related]
5. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
[TBL] [Abstract][Full Text] [Related]
6. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
8. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
[TBL] [Abstract][Full Text] [Related]
9. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
10. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
[TBL] [Abstract][Full Text] [Related]
11. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B;
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531
[TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
[TBL] [Abstract][Full Text] [Related]
13. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.
Greene SK; Rett M; Weintraub ES; Li L; Yin R; Amato AA; Ho DT; Sheikh SI; Fireman BH; Daley MF; Belongia EA; Jacobsen SJ; Baxter R; Lieu TA; Kulldorff M; Vellozzi C; Lee GM
Am J Epidemiol; 2012 Jun; 175(11):1100-9. PubMed ID: 22582210
[TBL] [Abstract][Full Text] [Related]
14. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.
Wise ME; Viray M; Sejvar JJ; Lewis P; Baughman AL; Connor W; Danila R; Giambrone GP; Hale C; Hogan BC; Meek JI; Murphree R; Oh JY; Reingold A; Tellman N; Conner SM; Singleton JA; Lu PJ; DeStefano F; Fridkin SK; Vellozzi C; Morgan OW
Am J Epidemiol; 2012 Jun; 175(11):1110-9. PubMed ID: 22582209
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
Greene SK; Rett MD; Vellozzi C; Li L; Kulldorff M; Marcy SM; Daley MF; Belongia EA; Baxter R; Fireman BH; Jackson ML; Omer SB; Nordin JD; Jin R; Weintraub ES; Vijayadeva V; Lee GM
PLoS One; 2013; 8(6):e67185. PubMed ID: 23840621
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
Andrews N; Stowe J; Al-Shahi Salman R; Miller E
Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631
[TBL] [Abstract][Full Text] [Related]
18. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998-1999: the view from a sentinel network of neurologists.
Cuadrado JI; de Pedro-Cuesta J; Ara JR; Cemillán CA; Díaz M; Duarte J; Fernández MD; Fernandez O; García-López F; García-Merino A; Velasquez JM; Martínez-Matos JA; Palomo F; Pardo J; Tobías A;
Neurol Sci; 2004 Jun; 25(2):57-65. PubMed ID: 15221623
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
[TBL] [Abstract][Full Text] [Related]
20. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
